Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

glycerol

PETRUS PHARMACEUTICALS PTY LTD

glycerol (PETRUS PHARMACEUTICALS PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 20
Pipeline programs 2
News articles 1
Drug details — glycerol
Class
—
Route
—
Patents
20
Programs
2
Data quality
0.81
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

glycerol (PETRUS PHARMACEUTICALS PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN glycerol
Brand PETRUS PHARMACEUTICALS PTY LTD
Originator Lacuna Pharma Pty Ltd

Approval history

Authority Status Date
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Browse pipeline Sponsor programs
  1. PREVENT-MINS Phase 3 · COLLEGIUM PHARMACEUTICAL · Myocardial Injury after Noncardiac Surgery
  2. Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] Phase 1 · S.L · STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopment

Related patents

Browse patents Lacuna Pharma Pty Ltd patent hub

  1. US 12378231

    Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12215322

    Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12215321

    Modulators of diacyglycerol acyltransferase 2 (DGAT2)

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11312962

    Modulators of diacyglycerol acyltransferase 2 (DGAT2)

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10668161

    Therapeutic hyperbranched polyglycerol encapsulated biomolecules

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9624170

    4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9271962

    Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8115011

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 2010331426

    Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria

    Expires Wed Dec 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7745691

    Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7514096

    Triacylglycerols of enriched CLA content

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 2008255015

    COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES

    Expires Wed Oct 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7045326

    Mono- and diacylglycerol acyltransferases and methods of use thereof

    Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6344548

    Diacylglycerol o-acyltransferase

    Expires Mon Jan 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is glycerol?

glycerol (PETRUS PHARMACEUTICALS PTY LTD) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for glycerol?

PETRUS PHARMACEUTICALS PTY LTD is a marketed brand name for glycerol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.